PCMA applauds FDA decision to issue list of off-patent drugs with minimal competition

The FDA issued a list of drugs on which patents have expired and which have few or no competitors, and the agency said it wou -More

PBMs combat high prices for Rx drugs

Drugmakers set prices for their products as high as they believe the market will bear, writes managed care pharmacist John Jo -More

PCMA news release on FDA commissioner's commitment to increasing prescription drug competition

 -More

Bonnie's story: How her drug benefits provide access to affordable Rx

Watch the video. -More

Interchangeable biosimilars are coming, FDA official says

Interchangeable biosimilar drugs should be coming to the US market within two years, FDA official Leah Christl said.  -More

FDA has authority to waive REMS rules, commissioner says

The FDA has the authority to waive Risk Evaluation and Mitigation Strategies requirements when generic- and branded-drug make -More

Senate Republicans push back health care vote until after recess

Senate Majority Leader Mitch McConnell, R-Ky., announced Tuesday that a vote on the Better Care Reconciliation Act will be po -More

I can't give you a surefire formula for success, but I can give you a formula for failure: Try to please everybody all the time.

Herbert Bayard Swope, journalist